CWM
HAE icon

CIBC World Markets’s Haemonetics HAE Stock Holding History

CIBC World Markets’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$256K Buy
+3,190
New +$214K ﹤0.01% 1014
2025
Q2 		$464K Sell
6,213
-4,800
-44% -$318K ﹤0.01% 907
2025
Q1 		$700K Buy
11,013
+6,317
+135% +$430K 0.01% 837
2024
Q4 		$367K Buy
+4,696
New +$377K ﹤0.01% 848
2021
Q2 		– Sell
-5,457
Closed -$606K – 752
2021
Q1 		$606K Buy
+5,457
New +$675K ﹤0.01% 751

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CIBC World Markets's HAE Position: Q4 2025 in Review

CIBC World Markets opened a new position in Haemonetics (HAE) in Q4 2025: 3,190 shares worth $256K. The stake represents ﹤0.01% of the portfolio and ranks #1014 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in HAE as recently as Q2 2025.

CIBC World Markets first reported a position in HAE in Q1 2021 and has held it in 5 quarters since. The position peaked at $700K in Q1 2025. 328 funds tracked by Wall St. Rank hold HAE as of Q4 2025.

  • CIBC World Markets held 3,190 shares of Haemonetics worth $256K as of Q4 2025.
  • Haemonetics was a new CIBC World Markets position in Q4 2025.
  • Haemonetics made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #1014 holding.
  • CIBC World Markets first reported a position in Haemonetics in Q1 2021 and has held it in 5 quarters since.
  • CIBC World Markets's Haemonetics position peaked at $700K in Q1 2025.
  • 328 funds tracked by Wall St. Rank held Haemonetics as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.